Home > Insider Trading > Filing (0001225208-14-004138)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
310158	Merck & Co. Inc.	MRK	Pharmaceutical Preparations (2834)	221918501

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1181175	C Kenneth Frazier	One Merck Drive Whitehouse Station NJ 08889-0100	Chairman, President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-02-11	45,000	$48.24	304,349	No	4	M	Direct
Common Stock	Disposition	2014-02-11	41,520	$54.52	262,829	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2014-02-11	45,000	$0.00	45,000	$48.24

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2005-02-27	2014-02-26	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock - 401(K) Plan	3,445	Indirect	By 401(k)

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.47 to $54.60, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
Holdings include shares acquired in dividend reinvestment transactions.
Includes shares acquired and dividends through January 8, 2014, in the Merck U.S. Savings Plan, a 401(k) plan.